Quest Diagnostics Overview
Quest Diagnostics Target Price
Analysts' 12-month price predictions for DGX.
Share Price
$173.65
Average Target Price
$195.00
12.3% upside
12.3% upside1 analysts in the last 4 months
High: $195 | Low: $195
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-02 | Redburn PartnersJamie Clark | $195 | 12.3% upside |  |
| 2025-02-03 | Piper SandlerDavid Westenberg | $180 | 3.7% upside | |
| 2025-01-31 | Truist FinancialDavid MacDonald | $182 | 4.8% upside | |
| 2025-01-31 | Robert W. BairdEric Coldwell | $189 | 8.8% upside | |
| 2024-10-23 | CitigroupPatrick Donnelly | $185 | 6.5% upside | |
| 2024-10-23 | Leerink PartnersMichael Cherny | $165 |  5% downside | |
| 2024-10-23 | BarclaysStephanie Davis | $168 | 3.3% downside | |
| 2024-10-23 | Robert W. BairdEric Coldwell | $182 | 4.8% upside | |
| 2024-10-22 | CFRAPaige Meyer | $178 | 2.5% upside | |
| 2024-10-07 | Truist FinancialDavid MacDonald | $165 | 5% downside | |
| 2024-07-29 | Mizuho SecuritiesAnn Hynes | $160 | 7.9% downside | |
| 2024-07-24 | Robert W. BairdEric Coldwell | $154 | 11.3% downside | |
| 2024-07-15 | Truist FinancialDavid MacDonald | $158 | 9% downside | |
| 2024-04-25 | BarclaysStephanie Davis | $144 | 17.1% downside | |
| 2024-02-07 | JefferiesBrian Tanquilut | $155 | 10.7% downside | |
| 2023-02-03 | Wells Fargo | $140 | 19.4% downside | |
| 2023-01-06 | Morgan Stanley | $158 | 9% downside | |
| 2022-11-17 | Citigroup | $125 | 28% downside | |
| 2022-05-03 | Morgan Stanley | $142 | 18.2% downside | |
| 2022-04-25 | Wells Fargo | $150 | 13.6% downside | |
| 2022-04-09 | CitigroupRalph Giacobbe | $175 | 0.8% upside | |
| 2022-01-15 | Deutsche BankPito Chickering | $190 | 9.4% upside | |
| 2021-12-13 | KeyBancDonald Hooker | $170 | 2.1% downside | |
| 2021-09-09 | Credit SuisseA.J. Rice | $150 | 13.6% downside | |